Celularity Stock Performance
| CELUW Stock | USD 0.01 0 17.00% |
The firm shows a Beta (market volatility) of -2.76, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Celularity are expected to decrease by larger amounts. On the other hand, during market turmoil, Celularity is expected to outperform it. At this point, Celularity has a negative expected return of -0.0625%. Please make sure to confirm Celularity's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Celularity performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Celularity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Celularity is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
1 | Is Celularity Inc. Equity Warrant stock attractive for long term wealth building - Quarterly Portfolio Report Smart Swing Trading Techniques - newser.com | 11/10/2025 |
2 | Acquisition by Diamandis Peter of 47042 shares of Celularity subject to Rule 16b-3 | 11/19/2025 |
3 | Acquisition by Lim Kok Thay of 300000 shares of Celularity at 2.844 subject to Rule 16b-3 | 11/28/2025 |
4 | Is Celularity Inc. Equity Warrant stock attractive for ETFs - 2025 Trading Volume Trends Real-Time Volume Spike Alerts - Newser | 12/04/2025 |
5 | Celularity receives FDA warning over marketing claims - MSN | 12/08/2025 |
6 | Celularity secures 10 million financing from DoubleLine co-founder - Investing.com India | 12/22/2025 |
7 | Acquisition by Diamandis Peter of 125000 shares of Celularity subject to Rule 16b-3 | 12/29/2025 |
8 | Acquisition by Parks Diane L. of 30000 shares of Celularity subject to Rule 16b-3 | 01/12/2026 |
9 | Acquisition by John Haines of 216014 shares of Celularity at 0.434 subject to Rule 16b-3 | 01/22/2026 |
| Begin Period Cash Flow | 10.2 M | |
| Total Cashflows From Investing Activities | 514 K |
Celularity | Build AI portfolio with Celularity Stock |
Celularity Relative Risk vs. Return Landscape
If you would invest 2.08 in Celularity on November 9, 2025 and sell it today you would lose (1.25) from holding Celularity or give up 60.1% of portfolio value over 90 days. Celularity is currently producing negative expected returns and takes up 18.0278% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Celularity, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Celularity Target Price Odds to finish over Current Price
The tendency of Celularity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 99.0 |
Based on a normal probability distribution, the odds of Celularity to move above the current price in 90 days from now is about 99.0 (This Celularity probability density function shows the probability of Celularity Stock to fall within a particular range of prices over 90 days) .
Celularity Price Density |
| Price |
Predictive Modules for Celularity
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Celularity. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celularity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celularity Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Celularity is not an exception. The market had few large corrections towards the Celularity's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Celularity, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Celularity within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | -2.76 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.03 |
Celularity Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Celularity for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Celularity can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Celularity generated a negative expected return over the last 90 days | |
| Celularity has high historical volatility and very poor performance | |
| Celularity has some characteristics of a very speculative penny stock | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 20.54 M. | |
| Celularity has accumulated about 38 M in cash with (6.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Celularity has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Parks Diane L. of 30000 shares of Celularity subject to Rule 16b-3 |
Celularity Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Celularity Stock often depends not only on the future outlook of the current and potential Celularity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Celularity's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.9 M | |
| Cash And Short Term Investments | 738 K |
Celularity Fundamentals Growth
Celularity Stock prices reflect investors' perceptions of the future prospects and financial health of Celularity, and Celularity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celularity Stock performance.
| Return On Equity | -63.67 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (1.99) % | ||||
| Operating Margin | (2.43) % | ||||
| Revenue | 54.22 M | ||||
| Gross Profit | 20.54 M | ||||
| EBITDA | (43.71 M) | ||||
| Net Income | (57.89 M) | ||||
| Cash And Equivalents | 38 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 68.84 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | (0.71) X | ||||
| Cash Flow From Operations | (6.4 M) | ||||
| Earnings Per Share | (0.87) X | ||||
| Total Asset | 132.68 M | ||||
| Retained Earnings | (899.68 M) | ||||
| Working Capital | (33.12 M) | ||||
About Celularity Performance
Evaluating Celularity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Celularity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Celularity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 151.47 | 218.55 | |
| Return On Tangible Assets | (0.45) | (0.47) | |
| Return On Capital Employed | (0.56) | (0.59) | |
| Return On Assets | (0.50) | (0.53) | |
| Return On Equity | (7.53) | (7.91) |
Things to note about Celularity performance evaluation
Checking the ongoing alerts about Celularity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celularity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celularity generated a negative expected return over the last 90 days | |
| Celularity has high historical volatility and very poor performance | |
| Celularity has some characteristics of a very speculative penny stock | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 20.54 M. | |
| Celularity has accumulated about 38 M in cash with (6.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Celularity has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Parks Diane L. of 30000 shares of Celularity subject to Rule 16b-3 |
- Analyzing Celularity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celularity's stock is overvalued or undervalued compared to its peers.
- Examining Celularity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celularity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celularity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celularity's stock. These opinions can provide insight into Celularity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.